Literature DB >> 18481710

[Multi-central controlled study on acupuncture for treatment of cerebral infarction in restoration stage].

Zhi-Xin Yang1, Jin-Ling Bian, Jun-Feng Xu, Peng-Fei Shen, Jie Xiong, Jia-Kui Guo, Zhi-Long Zhang, Jun Li, Xue-Min Shi.   

Abstract

OBJECTIVE: To probe into long-term therapeutic effect and safety of Xingnao Kaiqiao acupuncture for treatment of cerebral infarction in restoration stage.
METHODS: Two hundred and thirty-four cases of cerebral infarction in restoration stage were randomly assigned to a Xingnao group and a routine group. The Xingnao group (n=116) were treated by Xingnao Kaiqiao acupuncture (once each day, for 4 weeks) and routine treatment of western medicine, and the routine group (n=118) were treated with routine acupuncture and the routine treatment of western medicine. They were followed-up for 6 months. The main indexes living, treatment and recurrence at the end of the following survey and the secondary indexes assessment of nervous functions at the end of the following survey, and the incidence rate of bad events in acupuncture were observed.
RESULTS: The death rate was 0.86% and the continuing treatment rate was 36.21% in the Xingnao group, and 1.69% and 36.44% in the routine group, with no significant difference between the two groups (both P>0.05) at the following-up of 6 months; the Xingnao group in decreasing recurrent rate and improving nervous function was better than the routine group (P<0.01); no severe adverse response was found in the 2 groups.
CONCLUSION: Xingnao Kaiqiao acupuncture is safe and it is superior to routine acupuncture in long-term therapeutic effect, decreasing recurrence rate, improving nervous function.

Entities:  

Mesh:

Year:  2008        PMID: 18481710

Source DB:  PubMed          Journal:  Zhongguo Zhen Jiu        ISSN: 0255-2930


  1 in total

1.  Systematic review of long-term Xingnao Kaiqiao needling effcacy in ischemic stroke treatment.

Authors:  Zhi-Xin Yang; Jia-Hong Xie; Yong-Ping Liu; Guang-Xin Miao; Ying-Han Wang; Sheng-Mei Wu; Yuan Li
Journal:  Neural Regen Res       Date:  2015-04       Impact factor: 5.135

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.